Zhicheng TAVR robot trial for severe aortic stenosis
Part of Heart & circulation clinical trials.
This trial tests a robot-assisted system for replacing a narrowed heart valve (aortic stenosis) without open-heart surgery. It is for older adults whose heart team says they need this procedure and whose anatomy fits the robot's design.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have severe narrowing of your aortic valve, as confirmed by tests like an ultrasound.
- Your heart team has decided you need a valve replacement through a catheter (not open surgery).
- Your blood vessels and heart shape are suitable for the robot to perform the procedure.
- You understand the trial, agree to join, and will come for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a robot-assisted arm that helps doctors perform TAVR (aortic valve replacement) with more control and precision. It may make the procedure safer and easier for patients with aortic stenosis.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
This trial tests a newer transcatheter (catheter-based) aortic valve replacement device to improve symptoms and safety in older adults with severe aortic stenosis. You may qualify if you’re too high-risk for open-heart surgery and the valve/artery measurements fit the device.
This trial tests a new heart valve replacement (TAVR) system in people with severe, symptomatic aortic stenosis. If you qualify, it may offer a less invasive option compared with open-heart valve surgery, while also helping researchers understand safety and early effectiveness.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
Hear when a new Aortic Stenosis Treated With TAVI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.